Incesu has been with AstraZeneca since 2000 and assumed her current role in May 2020. In 2021, the Middle East and Africa division recorded revenues of $1.2 billion. In February 2023, AstraZeneca partnered with the Saudi’s Ministry of National Guard Health Affairs and the King Abdullah International Medical Research Center to uplift the local research and development capabilities and enhance its innovation ecosystem. In December 2022, the company entered a strategic partnership with G42 Healthcare to manufacture pharmaceutical products in Abu Dhabi. Incesu was previously vice president of commercial strategy and international and company president for Türkiye at AstraZeneca.